Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
1994 • 1,995 citations
Autoimmunity to type II collagen an experimental model of arthritis.
1977 • 1,599 citations
Immunological Aspects of Demyelinating Diseases
1992 • 1,021 citations
Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens
1994 • 895 citations
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis
1988 • 838 citations
Peripheral deletion of antigen-reactive T cells in oral tolerance
1995 • 775 citations
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
1992 • 734 citations
Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
1992 • 726 citations
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.
1994 • 643 citations
Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis
1993 • 634 citations
Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis
1993 • 592 citations
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis
1994 • 530 citations
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans.
1985 • 463 citations
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
1991 • 450 citations
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
1996 • 428 citations
Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis
1983 • 418 citations
Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).
1996 • 415 citations
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
1988 • 404 citations
Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice.
1993 • 334 citations
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.
1995 • 310 citations
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
1990 • 288 citations
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
1989 • 284 citations
Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.
1993 • 280 citations
Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity
1993 • 280 citations
Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis.
1995 • 263 citations
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
1996 • 260 citations
Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin
1993 • 233 citations
T cell priming versus T cell tolerance induced by synthetic peptides.
1995 • 230 citations
Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
1988 • 170 citations
Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
1993 • 158 citations
Adjuvant polyarthritis iv. induction by a synthetic adjuvant: immunologic, histopathologic, and other studies
1980 • 146 citations
Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope
1996 • 140 citations
Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols.
1994 • 110 citations
Passive Transfer of Adjuvant-induced Arthritis and Allergic Encephalomyelitis in Rats using Thoracic Duct Lymphocytes
1969 • 96 citations
Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens.
1993 • 87 citations
Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin
1996 • 80 citations
Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice—implications for autoimmunity
1995 • 71 citations
A vridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes
1995 • 69 citations
Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
1994 • 61 citations
Development of human Th1 and Th2 cytokine responses: The cytokine production profile of T cells is dictated by the primary in vitro stimulus
1993 • 50 citations
Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.
1994 • 27 citations